🏥AHRQ Requests Evidence on Hypofractionated Radiation Therapy
Supplemental Evidence and Data Request on Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: A Systematic Review
Summary
The Agency for Healthcare Research and Quality (AHRQ) is seeking scientific information submissions from the public. Scientific information is being solicited to inform our review on Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: A Systematic Review, which is currently being conducted by the AHRQ's Evidence-based Practice Centers (EPC) Program. Access to published and unpublished pertinent scientific information will improve the quality of this review.
Agencies
- Health and Human Services Department
- Agency for Healthcare Research and Quality
Business Impact
$$ - Med
The regulatory notice concerns the AHRQ's request for evidence related to hypofractionated radiation therapy for prostate cancer. This involves compliance for healthcare organizations to submit scientific data, which may impact funding, research initiatives, and operational practices in relevant medical establishments.